Find Clinical Trials | Cedars-Sinai

379 results found

Esophagus, Stomach

Nivolumab + Paclitaxel + Ramucirumab in Advanced Gastric and Esophageal Adenocarcinoma

This study focuses on people who have advanced stomach or esophageal cancer that has spread. The purpose of the study is to compare the usual treatment alone (the combination of 2 drugs, paclitaxel and ramucirumab) ...

Other

Efgartigimod in Kidney Transplant Recipients With Antibody-Mediated Rejection

The goal of this study is to evaluate the safety and effectiveness of an experimental drug called efgartigimod and how it affects kidney rejection in kidney transplant patients diagnosed with antibody-mediated rejection (AMR). AMR develops ...

Other

Long-term Safety and Efficacy of Tulisokibart in Crohn’s Disease or Ulcerative Colitis

The purpose of this study is to evaluate the safety and effectiveness of an experimental drug called tulisokibart (MK-7240) compared with placebo (inactive substance) in people with Crohn’s disease or ulcerative colitis. The study focuses ...

Breast, Colon, Esophagus, Kidney, Lip, Oral Cavity and Pharynx, Liver ...

TEV-56278 as a Monotherapy and in Combination With Pembrolizumab in Selected Locally Advanced or Metastatic Solid Tumors

This study focuses on people who have a specific type of cancer that is either recurrent (has come back), locally spread, or metastatic (has spread to a different body part) and has not responded to ...

Breast, Cervix, Esophagus, Kidney, Liver, Lung, Melanoma, Other Female Genital ...

Phase 1/2 Study of CRB-601 in Patients With Advanced Solid Tumors

The purpose of this study is to determine whether an experimental drug called CRB-601 can help people with advanced solid tumors (cancer). The study aims to evaluate how well the drug is tolerated and identify ...